Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sara Duffett is active.

Publication


Featured researches published by Sara Duffett.


Alimentary Pharmacology & Therapeutics | 2002

The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial

James Mason; A. T. R. Axon; David Forman; Sara Duffett; Michael Drummond; Will Crocombe; Richard G. Feltbower; Su Mason; Julia Brown; Paul Moayyedi

Economic models have suggested that population Helicobacter pylori screening and treatment may be a cost‐effective method of reducing mortality from gastric cancer. These models are conservative as they do not consider that the programme may reduce health service peptic ulcer and other dyspepsia costs. We have evaluated the economic impact of population H. pylori screening and treatment over 2 years in a randomized controlled trial and have incorporated the results into an economic model exploring the impact of H. pylori eradication on peptic ulcer disease and gastric cancer.


European Journal of Gastroenterology & Hepatology | 2002

Establishing patient preferences for gastroenterology clinic reorganization using conjoint analysis

Paul Moayyedi; Mark Wardman; Jeremy Toner; Mandy Ryan; Sara Duffett

Objective The Department of Health states that patients with suspected cancer should be seen within 2 weeks, and the Patients’ Charter suggests that patients should not wait for more than 30 min in outpatients. Decisions such as these are often made with little assessment of patient preferences. We have elicited patient preferences for the optimal use of time in the outpatient clinic. Design Questionnaire survey eliciting preference between different clinic scenarios evaluated using discrete choice conjoint analysis. Setting and participants Patients attending a teaching hospital gastroenterology outpatient clinic. Main outcome measures The relative importance of time spent on the waiting list, time waiting in the clinic, time spent with the specialist, and time waiting for investigation was assessed using a logit model. Results Patients placed a similar value on waiting for investigation and time spent on the waiting list. A clinic that had a 2-month waiting list but offered immediate investigations would therefore be more popular than a clinic that had a 2-week waiting list but whose investigations were deferred for 3 months. Patients would be prepared to spend an extra 30 min in the waiting room if they spent 1 month less on the waiting list or waiting for investigation. Time spent with a specialist is valued, and patients would be prepared to spend an extra 3 min waiting in the clinic for every extra minute spent with the doctor. Conclusions The present Department of Health recommendations and the Patients’ Charter are too simplistic and do not take into account patient preferences.


International Journal of Epidemiology | 2002

Relation of adult lifestyle and socioeconomic factors to the prevalence of Helicobacter pylori infection

Paul Moayyedi; A. T. R. Axon; Richard G. Feltbower; Sara Duffett; Will Crocombe; David Braunholtz; Id Gerald Richards; Anthony Dowell; David Forman


European Journal of Epidemiology | 2005

The association between Helicobacter pylori infection and adult height

Paul Moayyedi; David Forman; Sara Duffett; Su Mason; Julia Brown; Will Crocombe; Richard G. Feltbower; A. T. R. Axon


International Journal of Technology Assessment in Health Care | 1999

Population-based and opportunistic screening and eradication of Helicobacter pylori. An analysis using trial baseline data. Leeds H. pylori Study Group.

James Mason; Paul Moayyedi; Philip Young; Sara Duffett; Will Crocombe; Michael Drummond; A. T. R. Axon


International Journal of Technology Assessment in Health Care | 1999

POPULATION-BASED AND OPPORTUNISTIC SCREENING AND ERADICATION OF HELICOBACTER PYLORI

James Mason; Paul Moayyedi; Philip Young; Sara Duffett; Will Crocombe; Michael Drummond; A. T. R. Axon


Gastroenterology | 2001

The appropriateness of measuring the benefit of dyspepsia management in terms of quality adjusted life years

Paul Moayyedi; Sara Duffett; Shelly Soo; A. T. R. Axon


Gastroenterology | 2000

Knowledge of a negative 13C-urea breath test reduces health care utilisation for dyspepsia in a population H pylori test and treat program

Paul Moayyedi; Richard G. Feltbower; Sara Duffett; Will Crocombe; David Forman; A. T. R. Axon


International Journal of Technology Assessment in Health Care | 1999

Population-based and opportunistic screening and eradication of Helicobacter pylori: An analysis using trial baseline data

James Mason; Paul Moayyedi; Philip Young; Sara Duffett; Will Crocombe; Michael Drummond; A. T. R. Axon


Gastroenterology | 2000

Establishing patient preferences for one-stop gastrointestinal clinics using conjoint analysis

Paul Moayyedi; Mark Wardman; Jeremy Toner; Sara Duffett; A. T. R. Axon

Collaboration


Dive into the Sara Duffett's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David Forman

International Agency for Research on Cancer

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge